These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16884399)

  • 1. Effect of kidney transplantation on bone.
    Kodras K; Haas M
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():63-75. PubMed ID: 16884399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Kidney transplantation: prevention and treatment for bone loss after transplantation].
    Kokado Y
    Clin Calcium; 2006 Jan; 16(1):86-91. PubMed ID: 16397356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series.
    Amerling R; Harbord NB; Pullman J; Feinfeld DA
    Blood Purif; 2010; 29(3):293-9. PubMed ID: 20090316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Markers of calcium--phosphate metabolism and bones alterations in long term kidney transplant patients].
    Spiechowicz U; Kokot F; Wiecek A
    Przegl Lek; 2003; 60(11):690-4. PubMed ID: 15058034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?
    Ghazali A; Fardellone P; Pruna A; Atik A; Achard JM; Oprisiu R; Brazier M; Remond A; Morinière P; Garabedian M; Eastwood J; Fournier A
    Kidney Int; 1999 Jun; 55(6):2169-77. PubMed ID: 10354266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphophonates in CKD patients with low bone mineral density.
    Liu WC; Yen JF; Lang CL; Yan MT; Lu KC
    ScientificWorldJournal; 2013; 2013():837573. PubMed ID: 24501586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of hemodialysis, vitamin D metabolites and renal transplantation on the skeletal demineralization associated with renal osteodystrophy: a computerized histomorphometric analysis.
    Main J; Velasco N; Catto GR; Fraser RA; Edward N; Adami S; O'Riordan JL
    Clin Nephrol; 1986 Dec; 26(6):279-87. PubMed ID: 3542321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling.
    Rojas E; Carlini RG; Clesca P; Arminio A; Suniaga O; De Elguezabal K; Weisinger JR; Hruska KA; Bellorin-Font E
    Kidney Int; 2003 May; 63(5):1915-23. PubMed ID: 12675872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of mineral and bone disorder after kidney transplantation.
    Kalantar-Zadeh K; Molnar MZ; Kovesdy CP; Mucsi I; Bunnapradist S
    Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):389-403. PubMed ID: 22614626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D, parathyroid hormone, and bone mineral density status in kidney transplant recipients.
    Savaj S; Ghods FJ
    Iran J Kidney Dis; 2012 Jul; 6(4):295-9. PubMed ID: 22797100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic bone disease after renal transplantation.
    Haffner D; Schüler U
    Curr Opin Pediatr; 2014 Apr; 26(2):198-206. PubMed ID: 24535492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation.
    Monier-Faugere MC; Mawad H; Qi Q; Friedler RM; Malluche HH
    J Am Soc Nephrol; 2000 Jun; 11(6):1093-1099. PubMed ID: 10820173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Changes in Chronic Kidney Disease-Mineral and Bone Disorders and Associated Fractures After Kidney Transplantation.
    Perrin P; Kiener C; Javier RM; Braun L; Cognard N; Gautier-Vargas G; Heibel F; Muller C; Olagne J; Moulin B; Ohlmann S
    Transplantation; 2017 Aug; 101(8):1897-1905. PubMed ID: 27547867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of 1,25-dihydroxy vitamin D3 and 24,25-dihydroxy vitamin D3 in renal osteodystrophy.
    Muirhead N; Adami S; Sandler LM; Fraser RA; Catto GR; Edward N; O'Riordan JL
    Q J Med; 1982; 51(204):427-44. PubMed ID: 6760236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low bone turnover in patients with renal failure.
    Couttenye MM; D'Haese PC; Verschoren WJ; Behets GJ; Schrooten I; De Broe ME
    Kidney Int Suppl; 1999 Dec; 73():S70-6. PubMed ID: 10633468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of metabolic bone disease in the pre-end-stage renal disease setting.
    Coburn JW; Elangovan L
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S71-7. PubMed ID: 11443772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualized therapy to prevent bone mineral density loss after kidney and kidney-pancreas transplantation.
    Mainra R; Elder GJ
    Clin J Am Soc Nephrol; 2010 Jan; 5(1):117-24. PubMed ID: 19965527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
    Fahrleitner A; Prenner G; Kniepeiss D; Iberer F; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Leb G; Dobnig H
    Wien Klin Wochenschr; 2002 Aug; 114(15-16):717-24. PubMed ID: 12602117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.